Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(0.40) per share. This is a 48.15 percent decrease over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $2.63 million which beat the analyst consensus estimate of $1.62 million by 62.04 percent. This is a 111.52 percent increase over sales of $1.24 million the same period last year.
Jaguar Health Q1 EPS $(0.40) Down From $(0.27) YoY, Sales $2.63M Beat $1.62M Estimate
Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(0.40) per share. This is a 48.15 percent decrease over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $2.63
